Your browser doesn't support javascript.
loading
節目: 20 | 50 | 100
结果 1 - 1 de 1
过滤器
添加過濾器








年份範圍
1.
Sichuan Mental Health ; (6): 370-372, 2022.
文章 在 中文 | WPRIM | ID: wpr-987399

摘要

This paper reported a case of drug eruption in a male patient with first-episode schizophrenia. The patient received ziprasidone monotherapy, and experienced post-treatment remission of schizophrenic symptoms, while accompanied by drug eruption with fever and elevated white blood cell count. Even with antiallergic treatment, the eruption did not subside without discontinuation of ziprasidone, whereas the eruption resolved after discontinuation of ziprasidone. This case suggested that individual allergy history should be taken into account during the use of ziprasidone, and timely intervention of adverse skin reactions was essential to prevent the development of severe drug eruption.

搜索明细